2024 annual financial data
Radiopharm Theranostics 2024 Net margin
Direct answer
Net margin was -16,024.28%.
Operating income was -36,620,852 AUD and net income was -47,949,119 AUD.
Operating cash flow was -22,975,935 AUD.
Get free Radiopharm Theranostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 299,228 AUD
- Operating income
- -36,620,852 AUD
- Net income
- -47,949,119 AUD
- Operating cash flow
- -22,975,935 AUD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Radiopharm Theranostics financial years